Hemophagocytic lympohistiocytosis (HLH) syndrome – Primary HLH

For the following indications, there is insufficient or no evidence to support the use of IG. Alternatives to IG are often available.

RecommendationsImmunomodulatory doses of IVIG are not recommended for the treatment of Primary HLH.